Selank is an anxiolytic peptide-based drug developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a synthetic analog of human tetrapeptide phagocytosis peptide. The drugs in clinical trials provide continuous nootropic and anxioytic effects, which are useful for treating generalized anxiety disorder (GAD). Selank's advantage is that there are no sedative or cognitive side effects, and there is no related addiction withdrawal syndrome. Selank also has very low toxicity, with overdose that proves harmless and even up to 500 times the effective dose. When released, the drug to be used is a 0.15% aqueous solution, which is applied to the nasal mucosa. It is believed that this is the best method for absorbing peptide-based drugs. The drug can be used to suppress feelings and stimuli in people with anxiety and anxiety disorders and stimulate learning and memory in healthy people.

Specification

Appearance

White to off-white amorphous powder

Molecular Ion Mass

751.9 ±1

Amino Acid Composition

±10%

Purity (HPLC) :

NLT 98.0 %

Related Substances

Total impurities <2.0%

Any individual impurity: <1.0%

Acetic acid (HPLC)

≤15.0%

Water Content

≦8%

Bacterial Endotoxins : 

≦50EU/mg

For adults with anxiety and anxiety disorders, corresponding to the diagnostic criteria for generalized anxiety disorder, neurasthenia, and adaptation disorders.

Side effect of Selank 

With increased sensitivity to odor and taste, unpleasant taste may occur if the formulation reaches the mucous membrane of the pharynx from the nasal cavity. An allergic reaction to an individual intolerance may occur.